113 related articles for article (PubMed ID: 12055435)
1. Further evidence for the role of fibrosis in the pathobiology of rhinophyma.
Payne WG; Wang X; Walusimbi M; Ko F; Wright TE; Robson MC
Ann Plast Surg; 2002 Jun; 48(6):641-5. PubMed ID: 12055435
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology.
Pu LL; Smith PD; Payne WG; Kuhn MA; Wang X; Ko F; Robson MC
Ann Plast Surg; 2000 Nov; 45(5):515-9. PubMed ID: 11092361
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of the TGF-beta1 and TGF- beta2 isoforms in nasal polyps and in healthy mucosa.
Rostkowska-Nadolska B; Kapral M; Mazurek U; Gawron W; Preś K
Postepy Hig Med Dosw (Online); 2007 Nov; 61():702-7. PubMed ID: 18059253
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
5. Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma.
Payne WG; Ko F; Anspaugh S; Wheeler CK; Wright TE; Robson MC
Ann Plast Surg; 2006 Mar; 56(3):301-5. PubMed ID: 16508362
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma.
Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U
Eur J Cancer; 2001 Jan; 37(2):224-33. PubMed ID: 11166150
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
9. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps.
Coste A; Lefaucheur JP; Wang QP; Lesprit E; Poron F; Peynegre R; Escudier E
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1361-6. PubMed ID: 9865759
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of TGF-beta1 and TGF-beta3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions.
Chegini N; Kotseos K; Zhao Y; Bennett B; McLean FW; Diamond MP; Holmdahl L; Burns J
Hum Reprod; 2001 Jun; 16(6):1291-300. PubMed ID: 11387308
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton.
Molin DG; Bartram U; Van der Heiden K; Van Iperen L; Speer CP; Hierck BP; Poelmann RE; Gittenberger-de-Groot AC
Dev Dyn; 2003 Jul; 227(3):431-44. PubMed ID: 12815630
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
[TBL] [Abstract][Full Text] [Related]
13. Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma.
Naef M; Ishiwata T; Friess H; Büchler MW; Gold LI; Korc M
Int J Cancer; 1997 Apr; 71(2):131-7. PubMed ID: 9139831
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
Nilsson EE; Doraiswamy V; Skinner MK
Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
[TBL] [Abstract][Full Text] [Related]
15. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung.
Coker RK; Laurent GJ; Jeffery PK; du Bois RM; Black CM; McAnulty RJ
Thorax; 2001 Jul; 56(7):549-56. PubMed ID: 11413354
[TBL] [Abstract][Full Text] [Related]
16. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia.
Lee SY; Chuang JH; Huang CC; Chou MH; Wu CL; Chen CM; Hsieh CS; Chen CL
J Pediatr Surg; 2004 May; 39(5):702-8. PubMed ID: 15137003
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
18. Steady state levels of transforming growth factor-beta1 and -beta2 mRNA and protein expression are elevated in colonic tumors in vivo irrespective of dietary lipids intervention.
Raju J; McCarthy B; Bird RP
Int J Cancer; 2002 Aug; 100(6):635-41. PubMed ID: 12209600
[TBL] [Abstract][Full Text] [Related]
19. Involvement of transforming growth factor-β3 and betaglycan in the cytoarchitecture of postoperative omental adhesions.
Gómez-Gil V; Pascual G; Pérez-Köhler B; Cifuentes A; Buján J; Bellón JM
J Surg Res; 2014 Apr; 187(2):699-711. PubMed ID: 24332552
[TBL] [Abstract][Full Text] [Related]
20. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
